Medtech mergers and acquisitions went full pelt in October, with 30 deals announced and closed in the month, the highest level of activity so far this year. The surge of M&A activity trounced the 10 deals recorded in the same period last year (Also see "M&A Analysis: October Deal Volume Takes A Nosedive" - Medtech Insight, 7 November, 2016.) and was a major upturn on the 17 deals recorded in September. (Also see "M&A Analysis: Steady Goes September" - Medtech Insight, 9 October, 2017.)
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?